1. 71: Early experience with osimertinib as second line treatment for EGFR mutated non-small cell lung cancer (NSCLC) and detecting T790M mutations from plasma circulating tumour DNA (ctDNA). (January 2017) Authors: Lewis, P.J.; Cox, R.A. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. COVID RT – Assessing the Impact of COVID-19 on Radiotherapy in the UK. A National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Initiative in Partnership with the Royal College of Radiologists, the Society of Radiographers and the Institute of Physics and Engineering in Medicine. Issue 1 (January 2021) Authors: Lewis, P.J.; Morris, E.J.A.; Chan, C.S.K.; Darley, K.; Sebag-Montefiore, D.; Evans, M. Journal: Clinical oncology Issue: Volume 33:Issue 1(2021) Page Start: e69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Structure and Processes of Existing Practice in Radiotherapy Peer Review: A Systematic Review of the Literature. Issue 4 (April 2021) Authors: Lewis, P.J.; Court, L.E.; Lievens, Y.; Aggarwal, A. Journal: Clinical oncology Issue: Volume 33:Issue 4(2021) Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The Response of the UK Clinical Oncology Community to the COVID-19 Pandemic. Issue 8 (August 2020) Authors: Lewis, P.J.; Roques, T.W. Journal: Clinical oncology Issue: Volume 32:Issue 8(2020) Page Start: 493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗